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DISCUSSION
Effect of vancomycin and ceftazidime on Biofilm formation in Elizabethkingia
Strain Species
Vancomycin Ceftazidime 
MIC MBC MIC MBC
R26 anophelis 8 16 >256 >256
ATCC 33958 bruuniana 4 8 16 >256
KC1913 meningoseptica 64 64 >256 >256
G4071 miricola 4 8 >256 >256
G4070 occulta 8 16 256 >256
G4122 ursingii 2 4 4 16
Methods
Growth Conditions:
Heart infusion agar (HIA) supplemented with 5% defibrinated 
rabbit blood was used to grow and preserve working stocks of 
the bacteria. A single colony from the working stocks was 
placed in 3 ml Mueller-Hinton broth (MHB) and incubated at 
37oC (24 h, 200 rpm) to make an overnight culture. 
Minimum inhibitory and bactericidal (MIC/MBC) assays: 
MICs and MBCs for each type strain were determined using the 
microtiter method following standard CLSI guidelines6.
Biofilm Growth Conditions:
Parent strains for each species (Table 1) were tested in triplicate 
on 96 well microtiter plates with positive controls and the 
appropriate concentration of each antibiotic (Tables 2 and 3). 
Overnight cultures were diluted to an optical density at 600 nm 
(OD600nm) of 0.01 and100 µl of this diluted culture was used to 
inoculate each well. Plates were incubated at 37oC for 24, 48, or 
72 hr. 
Crystal Violet Biofilm Assay:
Following incubation the OD600nm was recorded, growth media 
was removed, and each well was rinsed with 100 μl autoclaved 
diH2O to remove any non-adherent cells. After washing, the 
biofilms were fixed with 100 μl 100% methanol for 15 min, and 
allowed to air dry until all methanol had evaporated. To visualize 
biofilms,100 μl of 0.2% crystal violet solution was added to each 
well for 5 min. Crystal violet was then removed and plates were 
thoroughly rinsed with diH2O (Figure 1). Biofilm formation was 
assessed by adding100 μl 95% ethanol to each well and then 
read at OD570nm with a BioTek Synergy H1 plate reader. Wells 
were considered positive for biofilm formation if the OD570 was ≥ 
mean OD570nm + 3 standard deviations of 3 uninoculated control 
wells.  
Table 1. MICs and MBCs (µg/ml) of the 6 type strains of Elizabethkingia. 
Isolate Species




Control Treatment Control Treatment Control Treatment
R26 anophelis 4 3 3 3 3 3 3
ATCC 
33958
bruuniana 2 2 3 3 3 3 3
KC1913 meningoseptica 32 3 0 3 1 3 3
G4071 miricola 2 1 3 3 3 3 3
G4070 occulta 4 3 3 3 3 3 3
G4122 ursingii 1 3 3 1 1 3 3
Isolate Species
24 hr 48 hr 72 hr
Control Treatment Control Treatment Control Treatment
R26 anophelis 3 3 3 3 3 3
ATCC 
33958
bruuniana 3 3 3 3 3 3
KC1913 meningoseptica 2 2 3 3 3 3
G4071 miricola 3 2 2 3 3 3
G4070 occulta 3 3 3 3 3 3
G4122 ursingii 3 0 3 1 3 0
Table 3. Biofilm formation for each type strain in the presence of ceftazidime.  Each strain was 
challenged at a concentration of 32 µg/ml.
Table 2. Biofilm formation for each type strain in the presence of vancomycin. 
Each strain was challenged at ½ MIC. 
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Figure 1.  96 microtiter plate after rinsing out excess crystal violet.
Results
• The isolates demonstrated varied MICs and MBCs for vancomycin and 
ceftazidime (Table 1).
• All species were able to form biofilms in drug free media (Tables 2 and 3). 
Some controls for strains G4071 and G4122 however did not form biofilms, 
which we suspect is due to experimental error (Tables 2 and 3).
• With the exception of KC1913 (with vancomycin at 24 and 48 hr) and G4122 
(with ceftazidime at all time points examined), neither vancomycin (@ 0.5 X the 
MIC concentration) nor ceftazidime impacted biofilm formation at any time 
point examined. (Tables 2 and 3).
• KC1913 did however form biofilms after 72 hr, suggesting the selection for 
vancomycin resistance (Table 2).
• The concentration of 32 ug/ml ceftazidime used on G4122 (Table 3) was higher 
than the observed MIC, and it is likely that the lack of biofilm formation is due 
cell death. 
Introduction
Elizabethkingia infection primarily occurs in neonates and 
other immunocompromised individuals. Infections with these 
organisms are associated with a high mortality rate in part, 
due to their expression of multiple antibiotic resistance1,2. 
Vancomycin has been used to treat Elizabethkingia infections, 
but the treatment outcomes compared to in vitro
vancomycin susceptibility testing have produced conflicting 
results3. Elizabethkingia can also form biofilms, which are 
groups of bacterial cells that assemble into a matrix, creating 
a defensive barrier against antibiotics and the immune 
response4,5. Biofilm formation may be altered when cells are 
exposed to concentrations of antibiotics that are too low to kill 
the organism, but this has not been tested in Elizabethkingia. 
Our study seeks to test the effects of vancomycin and 
ceftazidime on biofilm formation of all known Elizabethkingia 
species.
Conclusions
• Our results demonstrates that vancomycin can 
impact biofilm formation in Elizabethkingia 
meningoseptica and ceftazidime (> MIC) can 
impact biofilm formation in Elizabethkingia 
ursingii.
• Overall though, vancomycin seems ineffective 
in reducing biofilm formation in the 
Elizabethkingia.
